RxDoctor Payments Data

Olga Kligerman, DO

Hematology & Oncology · East Syracuse, NYNPI 1316159601

Payments from drug & device makers

$77in general payments, 2019–2025

Across 5 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Welch Allyn$34
  • Karyopharm Therapeutics Inc.$12
  • Merck$12
  • Gilead$12
  • Clovis Oncology, Inc.$7

What the payments were for

  • Food & beverage$1925%
  • Education$2432%
  • Gifts$3444%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$77 in reported general payments places this provider in the 5th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York

Medicare billing

Part B allowed, 2024
$3,794,306
Medicare patients
682
Services billed
198,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole91$950
Letrozole42$327

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in East Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →